Overview

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Status:
Terminated

Trial end date:
2013-01-01

Target enrollment:

Participant gender:

Summary

The objective was to evaluate the efficacy and safety of combination of beraprost and aspirin for prevention of arteriosclerosis progress in type 2 diabetes mellitus patients.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Aspirin
Beraprost
Epoprostenol